Search the GHTC website
March 2024

Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World

Examines the blockbuster returns from US government investment in global health R&D, including the lifesaving tools advanced and the economic and health benefits generated globally and domestically.

January 2023

Recommendations for the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2023

Ahead of the 2023 reauthorization of the Biomedical Advanced Research and Development Authority (BARDA), the Pandemic and All Hazards Preparedness Act (PAHPA) 2023 policy memo outlines GHTC’s priorities for the reauthorization of BARDA. 

August 2022

Navigating complexity to improve global access: Supporting a more efficient and effective World Health Organization Prequalification Program

Examines successes and pain points of the World Health Organization’s (WHO) Prequalification Program, which facilitates global access to safe, effective, and quality-assured products, and offers actionable recommendations to WHO to continue to strengthen the program to make it more fit for purpose for an evolving regulatory ecosystem

January 2022

Pandemic R&D Agenda for Action: Fostering Innovation To End This Pandemic and Prepare for the Next One

Calls on world leaders to prioritize action in four key areas to close the critical R&D, manufacturing, and delivery gaps necessary to end the acute COVID-19 crisis and build a more resilient, equitable pandemic R&D ecosystem for the future.

Stay updated

Find out about GHTC’s membership options and the benefits of becoming a member.

Learn More